Blood pressure

Global Air purifier Market Size is Projected to USD 21.15 Bn by 2027 Says Brandessence Market Research

Retrieved on: 
Friday, November 26, 2021

Studies suggest that portable air purifier systems reduce the penetration of PM 2.5 particles between 22.6% to 92% on average.

Key Points: 
  • Studies suggest that portable air purifier systems reduce the penetration of PM 2.5 particles between 22.6% to 92% on average.
  • The portable air purifier market remains the brightest spot for growth in the air purifiers market.
  • The air purifier market report is divided into air purifier segmentations by technology into HEPA, Ionic Filters, Activated Carbons, among others.
  • The HEPA systems are likely to remain a significant force in the air purifier market, however, new technology is likely to drive fastest pace of growth in the air purifier segmentations.

Global Air purifier Market Size is Projected to USD 21.15 Bn by 2027 Says Brandessence Market Research

Retrieved on: 
Friday, November 26, 2021

LONDON, Nov. 26, 2021 /PRNewswire/ -- Air pollution is one of the most prevalent concerns, due to worsening environmental condition. According to Health Effect Institute, it accounts for 4.9 million to 8.8 million deaths worldwide each year. Furthermore, as most of our time is spent is indoors, indoor air pollution remains a serious concern to individuals, as well as regulatory agencies. Particles like PM 2.5 can enter indoors through a wide range of sources including car engines, fireplaces, and coal- or natural gas and the infiltration of ambient particulates in urban areas. Even in the absence of solid fuels, indoor ventilation can build up PM 2.5 particles to a greater extent than in outdoor environment. Growing demand for portable air purification filters, and systems in urban areas, increased advancements to catch key particulates like coronavirus, and increased regulatory measures to ensure safe environment for professionals in the industrial sector remain leading drivers of growth in the air purifier market. 

Key Points: 
  • Studies suggest that portable air purifier systems reduce the penetration of PM 2.5 particles between 22.6% to 92% on average.
  • The portable air purifier market remains the brightest spot for growth in the air purifiers market.
  • The air purifier market report is divided into air purifier segmentations by technology into HEPA, Ionic Filters, Activated Carbons, among others.
  • The HEPA systems are likely to remain a significant force in the air purifier market, however, new technology is likely to drive fastest pace of growth in the air purifier segmentations.

Global Flavored Water Market Report 2021: Increasing Consumer Preference for Healthy Alternatives to Sugary Soft Drinks - Market Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 24, 2021

The global flavored water market size is expected to reach USD 29.56 billion by 2028, registering a CAGR of 10.3% over the forecast period

Key Points: 
  • The global flavored water market size is expected to reach USD 29.56 billion by 2028, registering a CAGR of 10.3% over the forecast period
    Increasing consumer preference for healthy alternatives to sugary soft drinks is the major factor driving the market growth.
  • The sparkling product segment dominated the market with the largest revenue share in 2020.
  • The sparkling waters with added benefits of fruits and herbs have a high demand as it is a healthy alternative to fizzy drinks.
  • Over the years, sparkling drinks with low or zero sugar and zero-calorie content are gaining popularity among young health-conscious consumers.

YHE Technology Launches World's 1st Medical-Grade Smartwatch - BP Doctor MED

Retrieved on: 
Wednesday, November 24, 2021

The Story behind YHE BP Doctor MED

Key Points: 
  • New York, New York--(Newsfile Corp. - November 24, 2021) - Personal medical device experts YHE Technology have announced the launch of BP Doctor MED - A Medical-Grade Blood Pressure Smartwatch.
  • Continuous advances were made and from BP Doctor Pro to BP Doctor MED, YHE has succeeded in improving the average accuracy by 50%.
  • Although we have a great deal of experience in the wearable wellness industry and successfully launched BP Doctor Pro - the first multi-functional blood pressure smartwatch, the journey of developing BP Doctor MED was still a challenge.
  • Our ambition was to make BP Doctor MED the first medical-grade blood pressure smartwatch in the world.

IgA Nephropathy (IgAN): Global Market Insights, Epidemiology, and Forecast to 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 24, 2021

The "IgA Nephropathy (IgAN) - Market Insights, Epidemiology, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "IgA Nephropathy (IgAN) - Market Insights, Epidemiology, and Market Forecast - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The disease epidemiology covered in the report provides historical and forecasted IgA nephropathy epidemiology segmented as the prevalence of IgA nephropathy, gender-specific cases of IgA nephropathy, and age-specific cases of IgA nephropathy.
  • The report provides an edge while developing business strategies by understanding trends shaping and driving the global IgA nephropathy market.
  • To understand the future market competition in the IgA nephropathy market and an Insightful review of the key market drivers and barriers.

American College of Lifestyle Medicine Designates Rochester Lifestyle Medicine Institute's Jumpstart Program as Certified Lifestyle Medicine Program

Retrieved on: 
Tuesday, November 23, 2021

ST. LOUIS, Nov. 23, 2021 /PRNewswire-PRWeb/ --The American College of Lifestyle Medicine (ACLM) today announced that the Rochester Lifestyle Medicine Institute (RLMI) Jumpstart Program has earned Certified Lifestyle Medicine Program designation.

Key Points: 
  • ST. LOUIS, Nov. 23, 2021 /PRNewswire-PRWeb/ --The American College of Lifestyle Medicine (ACLM) today announced that the Rochester Lifestyle Medicine Institute (RLMI) Jumpstart Program has earned Certified Lifestyle Medicine Program designation.
  • In June, the Rochester Lifestyle Medicine Institute announced it would expand the program to all of North America and internationally.
  • "ACLM is excited to recognize Rochester Lifestyle Medicine Institute's 15-Day WFPB Jumpstart as a Certified Lifestyle Medicine Program," said ACLM President Cate Collings, MD, MS, FACC, DipABLM.
  • ABOUT ROCHESTER LIFESTYLE MEDICINE INSTITUTE:
    Rochester Lifestyle Medicine Institute advocates for treating the root causes of lifestyle-based chronic conditions.

AnyCARE Introduces a TAP2 Health Monitor Smartwatch, AnyCARE Family Connect and AnyCARE Help Connect

Retrieved on: 
Tuesday, November 23, 2021

Our innovative health smartwatch scans the wearer's vitals regularly, and shares the information with all family members connected through the AnyCARE Family Connect app to enhance the health and safety of the loved ones.

Key Points: 
  • Our innovative health smartwatch scans the wearer's vitals regularly, and shares the information with all family members connected through the AnyCARE Family Connect app to enhance the health and safety of the loved ones.
  • AnyCARE TAP2 Smartwatch as a Self-Health Monitor All health information is shared between the TAP2 Smartwatch and theAnyCAREFamily Connect app on their cell phone.
  • AnyCARE TAP2 smartwatch with Help Connect Service- This plan allows for all the great benefits of the Smartwatch plan with the addition of the Help SOS Alerts feature.
  • The subscription fee forthe Family Mode optionin the AnyCARE Family Connect appis$4.99 permonth for the User only.There is no charge to family, friends and neighbors for the AnyCARE Help Connect app.

OMRON Healthcare Issues National Health Alert: Adults with High Blood Pressure Could Face Higher Heart Attack and Stroke Risk During Cold & Flu Season

Retrieved on: 
Tuesday, November 23, 2021

"Seasonal flu is common, and it presents a significant risk to those who have high blood pressure.

Key Points: 
  • "Seasonal flu is common, and it presents a significant risk to those who have high blood pressure.
  • OMRON Healthcare is offering these tips to manage cardiac event risk during cold and flu season:
    Monitor your blood pressure regularly Your blood pressure changes over time and can even fluctuate during the day.
  • Our connected blood pressure monitors sync with our OMRON Connect app, which offers insights and coaching for better heart health."
  • While numerous health issues may factor into increased heart attack risk from respiratory infection, blood pressure continues to be an important heart health metric to track.

Research Finds U.S. Cardiogenic Shock Patients Have High Hospital Inpatient Mortality and Long Length of Stay – Adding to Previously Reported Need for New Pharmacologic Innovation

Retrieved on: 
Monday, November 22, 2021

Cardiogenic shock is a serious condition that occurs when the heart cannot pump enough blood and oxygen to the brain, kidneys, and other vital organs.

Key Points: 
  • Cardiogenic shock is a serious condition that occurs when the heart cannot pump enough blood and oxygen to the brain, kidneys, and other vital organs.
  • U.S. hospital claims data reveals that inpatient mortality for cardiogenic shock patients was 30% in 2020.2 To help explain the relative severity of cardiogenic shock, the acute myocardial infarction (e.g.
  • Additionally, U.S. hospital claims data was assessed to determine length of stay in the hospital for cardiogenic shock patients.
  • The istaroxime phase 2 study in early cardiogenic shock is an international, randomized, double blind, placebo- controlled study.

CareDx Enrolls First Patients in the Largest Digital Study in Transplant Using AlloCare to Assess Patient Outcomes

Retrieved on: 
Thursday, November 18, 2021

SOUTH SAN FRANCISCO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced the enrollment of the first patients in what will be the largest ever digital study measuring the impact of AlloCare™, a tech-enabled mobile health app, on organ transplant patient outcomes.

Key Points: 
  • The study arm will have patients trained for regular use of the AlloCare mobile health app.
  • This study will test the hypothesis that using AlloCare will empower solid organ transplant patients and their caregivers to achieve better adherence and, ultimately, better outcomes.
  • CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients.
  • CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.